Researchers explore new ways to prevent spinal cord damage using a vitamin B3 precursor: nicotinamide adenine dinucleotide ( NAD+ )

2009 study posted for filing Contact: Andrew Klein ank2017@med.cornell.edu 212-821-0560 New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College Weill Cornell Medical College team receives $2.5 million New York State research grant to undertake laboratory study NEW YORK (November 5, 2009) — Substances naturally produced by the human body may one day help prevent…

Pain drug can kill resistant tuberculosis: Researchers claim may never be tested in TB clinical trials.

Public release date: 10-Sep-2012 [Print | E-mail| Share][ Close Window ] Contact: Lauren Woods law2014@med.cornell.edu 212-821-0560 New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College Researchers find low cost drug wipes out drug resistant TB, but worry it may not reach patients in need NEW YORK (September 10, 2012) — An off-patent anti-inflammatory drug…